Coronavirus Vaccine

Judge Denies Kennedy's Request To Restore His Vaccine Videos On Youtube

The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference

AstraZeneca Resumes Coronavirus Vaccine Trials In U.K. After Independent Committee Approves of Safety

The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference

AstraZeneca Resumes Coronavirus Vaccine Trials In U.K. After Independent Committee Approves of Safety

AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 Participants

Elon Musk Heads To Germany To Assess Tesla Giga Berlin, Vaccine Printer Progress

AstraZeneca COVID-19 Vaccine Candidate Moves Into Late-Stage US Clinical Trials With 30,000 Participants

Elon Musk Heads To Germany To Assess Tesla Giga Berlin, Vaccine Printer Progress

FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FT

CanSino, Canada End COVID-19 Vaccine Collaboration, Citing Chinese Bureaucratic Hurdles

Coronavirus Vaccine Recent News

AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FT

COVID-19 vaccine makers are lobbying the European Union for protection against lawsuits should problems arise with new therapies, the Financial Times reported Tuesday.

Ex-FDA Commissioner Analyzes Johnson & Johnson's Mega Vaccine Trial

Johnson & Johnson (NYSE: JNJ) plans on enrolling up to 60,000 people in a coronavirus vaccine trial, likely as part of a global development and regulatory approval strategy, ex-FDA Commissioner Scott Gottlieb said Friday on

Pfizer, BioNTech Say Second Coronavirus Vaccine Shows Fewer Side Effects Than Their First Candidate

Pfizer Inc (NYSE: PFE), and its partner BioNTech SE (NASDAQ: BNTX), announced positive results for the Phase 1 trial of their second COVID-19 vaccine candidate, stating that the latest vaccine candidate had fewer side effe

CanSino Gets China's First COVID-19 Vaccine Patent

CanSino Biologics Inc (OTC: CASBF) has become the first company to secure a patent for its COVID-19 vaccine in China, Reuters

Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal

Novavax, Inc (NASDAQ: NVAX) announced Friday it has reached terms with the government of the United Kingdom to supply 60 million doses of its COVID-19 vaccine, when, and if, it receives regulatory approval.

AstraZeneca Inks Deal With Mexico, Argentina For Production, Supply Of Its COVID-19 Vaccine To Latin America

AstraZeneca plc’s (NYSE: AZN) COVID-19 vaccine will be produced by Mexico and Argentina for Latin American countries except for Brazil, according to government officials of the two countries, AlJazeera reported Wednesday.

Activist Investor Nelson Peltz Says He Is Putting New Capital To Work

Activist investor and Trian Partners CEO Nelson Peltz told CNBC on Thursday's "Halftime Report" he bought shares of unnamed companies that were "beaten down too much."

Novavax Continues Huge Run, Short Seller Sees It Falling Back To $15

Shares of Novavax, Inc. (NASDAQ: NVAX) gained more than 25% by Monday, leading a notable short seller to tweet his thoughts on the stock.